StonvexLoading…
StonvexStonvexStonvexCore line items from BR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.26B | $3.30B | $1.59B | $6.89B |
Operating Income | $754.30M | $394.80M | $188.80M | $1.19B |
Net Income | $726.20M | $450.00M | $165.40M | $839.50M |
EPS (Diluted) | $6.18 | $3.82 | $1.40 | $7.10 |
Total Assets | $8.78B | $8.64B | $8.30B | $8.54B |
Total Liabilities | $5.96B | $5.76B | $5.67B | $5.89B |
Cash & Equivalents | $304.80M | $370.70M | $290.70M | $561.50M |
Free Cash Flow OCF − CapEx | $633.10M | $345.60M | $27.10M | $1.13B |
Shares Outstanding | 115.70M | 116.70M | 116.70M | 117.10M |